Muutke küpsiste eelistusi

Handbook of Nutrition, Diet, and the Eye 2nd edition [Kõva köide]

Edited by (Professor, Mel and Eni), Edited by (Professor, Department of Clinical Biochemistry, Kings College Hospital, London, UK; Emeritus Professor, Faculty of Life Sciences and Medicine, Kings College London, UK Visiting Professor, University of Hull, UK)
  • Formaat: Hardback, 668 pages, kõrgus x laius: 235x191 mm, kaal: 1500 g
  • Ilmumisaeg: 12-Jun-2019
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0128152451
  • ISBN-13: 9780128152454
Teised raamatud teemal:
  • Formaat: Hardback, 668 pages, kõrgus x laius: 235x191 mm, kaal: 1500 g
  • Ilmumisaeg: 12-Jun-2019
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0128152451
  • ISBN-13: 9780128152454
Teised raamatud teemal:

Handbook of Nutrition, Diet, and the Eye, Second Edition thoroughly addresses common features and etiological factors on how dietary and nutritional factors affect the eye. The ocular system is perhaps one of the least studied organs in diet and nutrition, yet the consequences of vision loss are devastating. There are a range of ocular defects that have either their origin in nutritional deficiencies/excess or have been shown to respond favorably to nutritional components. Featuring a new section on animal model studies where both the ocular problem and dietary remedies can be varied, there are also new chapters on dietary supplements.

  • Serves as a foundational collection for neuroscience, neurology and nutrition researchers, illustrating the importance of nutrition and diet in eye health and function
  • Provides a common language for readers to discuss how nutritional factors and related diseases and syndromes affect the eye
  • Features new chapters on infectious diseases of the eye where nutrition is a factor
  • Discusses animal model studies, dietary supplements, natural dietary extracts from around the world, and age-related changes in ocular health
Contributors xxi
Section A. Introductions and Overviews 1(14)
1 The Eye and Vision: An Overview
3(12)
R.A. Armstrong
R.C. Cubbidge
Introduction
4(1)
Development of the Eye
4(1)
The Ocular Adnexa
5(2)
The Anterior Structures of the Eye
7(3)
The Posterior Structures of the Eye
10(3)
Visual Pathway
13(1)
Summary Points
14(1)
References
14(1)
Section B. Macular Degeneration 15(150)
2 Overview of Risk Factors for Age-Related Macular Degeneration
17(14)
R.A. Armstrong
R.P. Cubbidge
Introduction
18(1)
Genetic Risk Factors
19(1)
Dietary Risk Factors
19(3)
Cardiovascular Risk Factors
22(1)
Sunlight
22(1)
Smoking
22(1)
Alcohol
23(1)
Discussion and Conclusions
24(1)
Summary Points
25(1)
References
25(5)
Further Reading
30(1)
3 Age-Related Macular Degeneration
31(16)
Philip P. Storey
Julia A. Haller
Introduction
32(1)
Epidemiology
33(1)
Risk Factors
34(1)
Pathogenesis
35(1)
Classification
36(1)
Natural History
37(1)
Retinal Imaging for the Diagnosis and Management of AMD
38(2)
Management
40(2)
Future Directions
42(1)
Summary Points
43(1)
References
43(4)
4 The Role of Lipids and Lipid Metabolism in Age-Related Macular Degeneration
47(26)
Christopher Fortenbach
Elissa Goldman
Amar U. Kishan
Shilpa Mathew
Bobeck S. Modjtahedi
Lawrence S. Morse
Introduction
47(1)
Retinal Lipids
48(5)
Mechanism and Pathogenesis of Age-Related Macular Degeneration
53(7)
Conclusion
60(1)
Summary Points
61(1)
Acknowledgment
62(1)
References
62(11)
5 Dietary Hyperlipidemia and Retinal Microaneurysms
73(12)
Maria Cristina de Oliveira Izar
Tatiana Helfenstein
Francisco Antonio Helfenstein Fonseca
Introduction
74(1)
Cardiovascular Risk Factors, Endothelial Dysfunction, and Inflammation
74(2)
Hypercholesterolemia and Retinal Vascular Lesions
76(1)
Obesity Metabolic Syndrome, and Retinopathy Signs
77(3)
Glycemia and Diabetic Retinopathy
80(1)
Blood Pressure and Retinal Vascular Lesions
80(1)
How to Keep Healthy
80(1)
Summary Points
81(1)
References
82(3)
6 Antioxidants and Age-Related Macular Degeneration
85(22)
Emina Colak
Lepsa Zoric
Introduction
85(1)
Generation of Oxidatively Modified Macromolecules: The Starting Point in the Pathogenesis of AMD
86(2)
The Organization of Antioxidant Defense System
88(1)
Antioxidant Protection of the Macular Region
88(2)
The Organization of Antioxidant Protection of Retina: The Nonenzymatic Antioxidants
90(7)
Enzymatic Antioxidant Defense
97(4)
References
101(6)
7 Dietary Patterns and Age-Related Macular Degeneration
107(20)
Alexandra P.M. de Koning-Backus
Jessica C. Kiefte-de Jong
Caroline C.W. Klaver
Introduction
108(1)
Single Nutrients Versus Dietary Patterns
108(2)
The Effects of Different Dietary Patterns and AMD
110(4)
General Dietary Guidelines for a Healthy Lifestyle and AMD
114(7)
Conclusion
121(1)
Summary Points
122(1)
References
122(5)
8 Resveratrol and the Human Retina
127(20)
Adela Pintea
Dumitrita Rugina
Introduction
129(1)
Chemical Structure and Derivatives of Resveratrol
129(1)
Bioavailability and Safety of Resveratrol
129(2)
Antioxidative Role of Resveratrol in Eye Diseases
131(3)
Resveratrol as Anti-VEGF Agent in Eye Diseases
134(4)
Resveratrol as a Sirtuin Activator
138(3)
Summary Points
141(1)
References
141(6)
9 Vitamin D and Age-Related Macular Degeneration
147(18)
Yao Jin
Chen Xi
Jiang Qin
Ji Yong
Introduction
147(1)
Vitamin D
147(3)
Age-Related Macular Degeneration
150(3)
Vitamin D and Age-Related Macular Degeneration
153(3)
How to Supply Vitamin D
156(4)
Prospective
160(1)
Summary Points
160(1)
References
160(5)
Section C. Glaucomas and Cataracts 165(126)
10 Glaucoma: An Overview
167(22)
Sergio Claudio Sacca
Carlo Alberto Cutolo
Tommaso Rossi
Introduction
168(1)
The Definition and Classification of Glaucoma
169(2)
Epidemiology
171(1)
Intraocular Pressure as a Risk Factor
172(2)
Pathogenesis of Glaucoma
174(9)
Conclusions
183(1)
Summary Points
183(1)
References
183(6)
11 Quercetin and Glaucoma
189(14)
Naoya Miyamoto
Kimitoshi Kohno
Introduction
189(1)
Oxidative Stress
190(1)
Oxidative Stress and Transcription
191(1)
Oxidative Stress and Glaucoma
192(1)
Oxidative Stress and TM
193(1)
Quercetin and Glaucoma
194(3)
Conclusions
197(1)
Summary Points
197(1)
References
198(5)
12 Glaucoma and Antioxidant Status
203(18)
Mehmet Tosun
Ramazan Yagci
Mesut Erdurmus
Introduction
203(3)
Oxidative Stress
206(2)
Oxidative Stress in the Pathophysiology of Glaucoma
208(1)
Antioxidants
209(1)
Enzymatic Antioxidants
210(1)
Nonenzymatic Antioxidants
211(1)
Antioxidant Status in Glaucoma
211(4)
Potential Value of Antioxidants for the Treatment of Glaucoma
215(1)
Summary Points
216(1)
References
216(5)
13 Role of Natural Products in Glaucoma Management
221(10)
Vasanti Suvarna
Megha Sarkar
Pramila Chaubey
Manikanta Murahari
Preeti C. Sangave
Introduction
222(1)
Natural Products and Glaucoma
222(6)
Conclusion
228(1)
Summary Points
228(1)
References
228(3)
14 Cataracts: An Overview
231(14)
Mesut Erdurmus
Huseyin Simavli
Bahri Aydin
Introduction
231(1)
Etymology
231(1)
Epidemiology
232(1)
Classification, Pathogenesis, and Risk Factors
232(4)
Clinical Presentation
236(1)
Diagnostic Evaluation
236(1)
Prevention
237(1)
Treatment
238(4)
Summary Points
242(1)
References
242(3)
15 Role of Amino Acids on Prevention of Lens Proteins Nonenzymatic Glycation In Vitro, in Senile, and Diabetic Cataract
245(26)
S. Zahra Bathaie
Fereshteh Bahmani
Asghar Farajzadeh
Introduction
246(1)
History and Overview of the Advanced Glycation End-Products
246(3)
Glycating Agents
249(1)
Different Advanced Glycation End-Products
249(1)
Advanced Glycation End-Products Formation in the Lens
250(1)
Effects of Advanced Glycation End-Products on Proteins Function
251(4)
Biological Detoxification of Advanced Glycation End-Products
255(1)
Prevention/Inhibition of Advanced Glycation End-Products Formation
256(3)
Inhibitory Effects of Amino Acids on Formation of Advanced Glycation End-Products and Cataract
259(6)
Summary Points
265(1)
References
266(5)
16 Diabetic Cataract and Role of Antiglycating Phytochemicals
271(20)
Vaishali Agte
Snehal Gite
Introduction
271(3)
Inhibitory Potential of Foods
274(1)
Inhibitory Potential of Single and Polyherbal/Ayurvedic Drugs
274(4)
Inhibitory Potential of Individual Phytochemicals
278(5)
Summary Points
283(1)
References
284(6)
Further Reading
290(1)
Section D. Other Eye Conditions 291(76)
17 Effects of Coffee and Tea on Ocular Health and Disease
293(10)
Idan Hecht
Zvia Burgansky-Eliash
Idit Maharshak
Asaf Achiron
Introduction
293(1)
Coffee, Tea, and Ocular Physiology
293(1)
Intraocular Pressure and Glaucoma
294(3)
Ocular Circulation and Microstructure
297(1)
Cornea and the Anterior Segment of the Eye
298(1)
Summary Points
298(1)
References
299(4)
18 Molecular Pathways, Green Tea Extract, (-)-Epigallocatechin Gallate, and Ocular Tissue
303(18)
Yao Jin
Chen Xi
Jiang Qin
Ji Yong
Introduction
303(1)
Molecular Pathway of Green Tea and (-) -Epigallocatechin Gallate
304(2)
Beneficial Effects of Green Tea Extract and (-)-Epigallocatechin Gallate on the Corneal Epithelium
306(3)
Antioxidant Effects of (-)-Epigallocatechin Gallate on Human Lens Epithelial Cells
309(4)
Protective Effects of (-)-Epigallocatechin Gallate on Retinal Pigment Epithelium Cells
313(1)
Effects on Ocular Hypertension and Glaucoma
314(1)
Benefits for Retinal Ischemia-Reperfusion Injury, Ophthalmic Artery, and Optic Nerve
315(1)
Other Effects
316(1)
How to Supply Green Tea Extract and Epigallocatechin Gallate
316(1)
Conclusions
317(1)
Summary Points
317(1)
References
318(3)
19 Dry Eye Disease and Essential Fatty Acids
321(12)
Sang Beom Han
Joon Young Hyon
Introduction
321(1)
Essential Fatty Acids and Dry Eye Disease
322(4)
Therapeutic Guidelines
326(1)
References
327(6)
20 Effect of Glucosamine on Intraocular Pressure
333(6)
Hamed Esfandiari
Nils A. Loewen
Introduction
333(1)
Glycosaminoglycans
333(1)
Glycosaminoglycans and the Eye
334(1)
Clinical Studies on the Effect of Glucosamine on IOP
335(1)
Conclusions
336(1)
Summary Points
336(1)
References
336(3)
21 Nutrition and Viral Infections of the Eye
339(12)
Robert Kelechi Obi
Juliet Adamma Shenge
Introduction
340(1)
Basic Nutrition
341(1)
Micronutrients and Deficiencies
341(2)
Beta-Carotene Rich Foods
343(1)
Omega-3 Rich Foods
343(1)
Vitamin C Rich Foods
343(1)
Vitamin E Rich Foods
344(1)
Zinc-Rich Foods
344(1)
Lutein- and Zeaxanthin-Rich Foods
344(1)
Riboflavin- and Niacin-Rich Foods
344(1)
Natural Treatment of Viral Eye Infections
344(3)
Conclusion
347(1)
Summary Points
347(1)
References
347(4)
22 Effects of Grape-Enriched Antioxidant Diet on Retinal Pigment Epithelium Organelles Under Oxidative Stress
351(16)
Francesca Mazzoni
Jade Vargas
Frances H. Kazal
Silvia C. Finnemann
Introduction
351(2)
Grape Consumption and Retinal Degeneration: Previous Studies
353(1)
Organelles Involved in Cellular Antioxidant Mechanisms
354(3)
Methionine Sulfoxide Reductase A, a Mitochondrial Enzyme Critical for RPE Function
357(3)
MsrA-/- Mice, a Model for Oxidative Stress
360(1)
Conclusions
361(1)
Summary Points
362(1)
References
363(4)
Section E. Obesity and Macronutrients 367(72)
23 The Impact of Low Omega-3 Fatty Acids Diet on the Development of the Visual System
369(28)
Poliana Capucho Sandre
Patricia Coelho de Velasco
Claudio Alberto Serfaty
Development of the Visual System
370(5)
Critical Periods for Brain Development
375(2)
Omega-3 and Brain Development
377(4)
Role of Omega-3 on the Development of Visual Connections
381(3)
Nutritional Restriction of Omega-3 Alters the Duration of Critical Periods of Plasticity
384(1)
Impact of n-3 Nutritional Restriction on Retinal Development
384(3)
Summary Points
387(1)
References
387(8)
Further Reading
395(2)
24 Interlinks Between Vitamin A and Retinopathy
397(18)
Rahul K. Reddy
Marc Comaratta
Introduction
397(1)
Vitamin A in the Diet
398(1)
History of Vitamin A and Retinopathy
398(1)
Vitamin A Absorption, Metabolism, and Transport
399(1)
The Role of Vitamin A in Vision and Eye Development
400(1)
Vitamin A Deficiency Retinopathy
400(1)
Demographics and Causes of Vitamin A Deficiency
401(1)
Diagnosis and Treatment
402(3)
The Role of Vitamin A in Other Retinal Disorders
405(3)
Summary Points
408(1)
References
409(6)
25 Molecular Aspects of Carotenoid Metabolizing Enzymes and Implications for Ophthalmology
415(10)
Lei Wu
Dingbo Lin
Introduction
415(1)
Carotenoid Metabolism-An Overview
416(1)
Carotenoids in the Colon
416(1)
Molecular Biology of BCO1 and BCO2
416(1)
BCO1 Genetics
417(1)
BCO2 Genetics
417(1)
Implications of BCO1 and BCO2 for Ophthalmology
418(1)
BCO2 Might or Might Not Be Enzymatically Active in the Human Retina
419(1)
BCO2 Knockout Mouse Models
419(1)
Conclusion
419(1)
Summary Points
420(1)
Acknowledgments
421(1)
References
421(4)
26 Interconnecting the Mediterranean Diet and Age-Related Macular Degeneration
425(14)
Jayne V. Woodside
Damian Cole
Ruth E. Hogg
Introduction
425(1)
Diet, Dietary Patterns, and AMD Risk
426(2)
The Mediterranean Diet
428(1)
Measuring Adherence to a MD: The MD Score (MDS)
429(3)
Epidemiologic Evidence Linking Adherence to a Med Diet and AMD Risk
432(2)
Conclusion
434(1)
Summary Points
434(1)
References
435(3)
Further Reading
438(1)
Section F. Micronutrients 439(74)
27 Optic Neuropathies Caused by Micronutrients Deficiencies
441(20)
Marco Spinazzi
Introduction
442(4)
Vitamin B1 (Thiamine) Deficiency
446(3)
Vitamin B12 (Cobalamin) Deficiency
449(3)
Folate Deficiency
452(2)
Copper Deficiency
454(1)
Epidemic Nutritional Optic Neuropathies
454(1)
Redefinition of Tobacco-Alcohol Amblyopia and Tobacco Optic Neuropathy and Their Link With Nutritional Status
455(1)
Summary Points
456(1)
References
457(4)
28 Vitamin C and L-Arginine in Retinal Cells and Its Relationship With the Visual System
461(24)
C.C. Portugal
R. Socodato
T.G. Encamacao
I. Domith
M. Cossenza
R. Paes-de-Carvalho
Introduction
462(1)
Vitamin C
462(7)
L-Arginine
469(8)
Ascorbate, L-Arginine, and Nitric Oxide Interplay in the Retina
477(2)
Summary Points
479(1)
References
479(6)
29 Bariatric (Weight-Loss) Surgery and the Eye
485(12)
Winsome Abbott-Johnson
Paul Kerlin
Introduction
485(1)
Restrictive and Malabsorptive Forms of Weight Loss Surgery
486(1)
Preoperative Nutrition
486(2)
Nutritional Consequences of Weight Loss Surgery
488(1)
Sequelae of Weight Loss Surgery for the Eye
488(1)
Vitamin A
488(3)
Thiamine
491(1)
Copper
492(1)
Nutrients That Have Potential Ocular Effects and Can Be Deficient Post Operatively
493(1)
Riboflavin (Vitamin B2)
493(1)
Vitamin B12, Folate, and Homocysteine
493(1)
Vitamin E
493(1)
Diabetic Retinopathy Following Weight Loss Surgery
493(1)
Recommended Vitamin/Mineral Supplementation After Weight Loss Surgery
494(1)
Summary Points
495(1)
References
495(1)
Further Reading
496(1)
30 Dietary Polyunsaturated Fatty Acids, Intraocular Pressure, and Glaucoma
497(16)
Niyazi Acar
Catherine P. Creuzot-Garcher
Alain M. Bron
Lionel Bretillon
Introduction
497(1)
Epidemiologic Data
498(5)
Laboratory Research
503(3)
Summary Points
506(3)
References
509(4)
Section G. Nutraceuticals 513
31 Anticataractogenic Potential of Dietary Spices in diabetic condition
515(14)
Krishnapura Srinivasan
Introduction
515(1)
Curcumin-The Bioactive Phytochemical of Turmeric (Curcuma Tonga)
516(3)
Crocin of Saffron (Crocus sativus)
519(2)
Fenugreek Seeds
521(1)
Garlic (Allium sativum) and Onion (Allium cepa)
521(2)
Ginger (Zingiber officinale)
523(1)
Cumin (Cuminum cymminum) Seeds
524(1)
Summary Points
525(1)
References
525(4)
32 Fruit and Vegetable Intake and the Macular Pigment Optical Density
529(22)
Begona Olmedilla-Alonso
Rocio Estevez-Santiago
Introduction
529(1)
Fruit and Vegetable Intake-An Indicator of Diet Quality and Food Sources of Nutrients and Bioactive Compounds
530(1)
Macular Pigment-A Long-Term Marker of Lutein and Zeaxanthin Status
531(2)
Associations Between Fruit and Vegetable Intake and the MPOD
533(11)
Dietary Intake Recommendations on Visual Health
544(1)
Summary Points
545(1)
References
545(6)
33 Gene Expression and the Impact of an Antioxidant Supplement in the Cataractous Lens
551(18)
Rho Hayashi
Introduction
552(1)
Antioxidants Are Expected to Prevent Cataract Progression
552(1)
Epidemiological Studies Resulted in Unclear Conclusions Regarding the Role of Nutrition in Cataract Prevention
553(1)
The Changes in G6PDH Are Possible Indicators for Measuring the Effects of Antioxidant Supplements on Cataract Prevention
554(1)
The Changes in 18S rRNA Could Also Be Used to Assess the Effects of Antioxidant Nutrients on Cataract Prevention
554(1)
The Changes in AQP8 and Gpx Could Be the Key to Determining How Oxidative Stress in the Aqueous Humor Affects the Lens
554(1)
Gene Expression Is a Good Indicator of Antioxidant Enzyme Production
555(1)
Gene Expression of G6PDH, 18S rRNA, AQP8, and Gpx Changed After Intake of a Lutein-Containing Supplement
555(9)
Conclusion
564(1)
Summary Points
564(1)
References
565(4)
34 Statins and Age-Related Macular Degeneration: Implications for Dietary Intake
569(16)
Marina Roizenblatt
Kim Jiramongkolchai
Nara Naranjit
Peter L. Gehlbach
General Concepts About Age-Related Macular Degeneration
569(3)
Lipids and Retinal Physiology
572(1)
Lipids and Age-Related Macular Degeneration
573(2)
Statins in AMD
575(3)
Conclusions
578(1)
Acknowledgments
579(1)
References
579(6)
35 Citicoline and Eye Health
585(20)
Pawel Grieb
Introduction
585(1)
Citicoline as a Source of Choline, Cytidine, and Phosphate
586(1)
Citicoline: A Neuroprotectant and Promoter of Neuroregeneration
587(2)
Citicoline: A Psychostimulant
589(1)
Citicoline as a Retinal Neuroprotectant
590(2)
Benefits of Citicoline for Patients With Glaucoma
592(1)
Citicoline for Eye Diseases Other Than Glaucoma
593(2)
Is Citicoline a Superior Choline Source?
595(2)
Summary Points
597(1)
References
598(7)
36 New Ultra-Structural Aspects of Cornea: Significance of Ascorbate Micronutrient Deficiency
605
Horacio M. Serra
Maria Fernanda Suarez
Introduction
606(13)
Summary Points
619(1)
Acknowledgments
620(1)
References
620
Index 62
Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at Kings College Hospital and Emeritus Professor of Nutritional Biochemistry at Kings College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at Kings College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books. Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watsons career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models.